cancer drug development
Top Tips on Assessing Molecular Systems of Response
January 19 by Helen WinsorKarol Sikora Medical Director at CancerPartners UK, joins Helen Winsor from Pharma IQ, to discuss new trial design approaches and biomarker application methods coming on stream to drive oncology cli...
The MHRA Review and Clinical Trials in Cancer
January 17 by Helen WinsorJames McBlane, Preclinical Assessor in the Clinical Trials Unit, Medicines & Healthcare products Regulatory Agency (MHRA), joins Pharma IQ to discuss clinical trials in patients with advanced...
Spearheading Economically Sustainable Scientific Strategies for Cancer
January 12 by Andrea CharlesProf. Dr. Ahmed Elzawawy, President of International Campaign for Establishment and Development of Oncology Centres (ICEDOC) & Co-President of South and East Mediterranean Colleg...
